Lisa Dalton
Keine laufenden Positionen mehr
Vermögen: 517 $ am 31.07.2023
Profil
Lisa Dalton served as the Head of Human Resources at Spark Therapeutics, Inc. from 2014 to 2019.
Prior to that, she was the Vice President of Human Resources at Shire Pharmaceuticals, Inc. She also served as an Independent Director at Nabriva Therapeutics Plc from 2021 to 2023.
Dalton received an undergraduate degree from The Pennsylvania State University and an MBA from Rutgers Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NABRIVA THERAPEUTICS PLC
0,01% | 31.01.2023 | 364 ( 0,01% ) | 517 $ | 31.07.2023 |
Ehemalige bekannte Positionen von Lisa Dalton
| Unternehmen | Position | Ende |
|---|---|---|
| NABRIVA THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 30.07.2023 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Personalreferent | - |
| SPARK THERAPEUTICS, INC. | Personalreferent | - |
Ausbildung von Lisa Dalton
| The Pennsylvania State University | Undergraduate Degree |
| Rutgers Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NABRIVA THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
